Profile for United States of America Patent: 2011184036
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for United States of America Patent: 2011184036
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
⤷ Sign Up | Jan 28, 2031 | Eagle Pharms | BELRAPZO | bendamustine hydrochloride |
⤷ Sign Up | Jan 28, 2031 | Eagle Pharms | BENDEKA | bendamustine hydrochloride |
⤷ Sign Up | Jan 28, 2031 | Eagle Pharms | BELRAPZO | bendamustine hydrochloride |
⤷ Sign Up | Jan 28, 2031 | Eagle Pharms | BENDEKA | bendamustine hydrochloride |
>US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |